Effectiveness of inactivated influenza vaccine in children less than 5 years of age over multiple influenza seasons: A case-control study

被引:23
|
作者
Joshi, Avni Y. [1 ]
Iyer, Vivek N.
St Sauver, Jennifer L. [2 ]
Jacobson, Robert M. [2 ]
Boyce, Thomas G. [2 ]
机构
[1] Mayo Clin, Mayo Grad Sch Med, Div Pediat Infect Dis, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA
关键词
Influenza; Trivalent Inactivated Influenza vaccine (TIV); Effectiveness; Children;
D O I
10.1016/j.vaccine.2009.05.038
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The effectiveness of influenza vaccine over multiple influenza seasons in children less than 5 years of age has not been well studied. This is especially important to assess because of the recent recommendation for routine influenza vaccination in childhood. We conducted a matched case-control study to assess the vaccine effectiveness of Trivalent Inactivated Influenza Vaccine (TIV) against laboratory-confirmed, medically attended influenza among children 6-59 months of age at the start of each influenza season from 1999-2000 through 2006-2007 in Olmsted County, MN, USA. The children vaccinated against influenza accordingly to the 2007 ACIP guidelines had a lower risk of laboratory-confirmed medically attended influenza illness (Odds Ratio: 0.14, 95% Confidence Interval: 0.03-0.71) than the unvaccinated children. TIV provided strong protection against laboratory-confirmed medically attended influenza in children 6-59 months old in the fully vaccinated group. This trend continued in the partially vaccinated group (Odds Ratio: 0.27, 95% Confidence Interval: 0.07-0.97) but the protection provided maybe suboptimal. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4457 / 4461
页数:5
相关论文
共 50 条
  • [21] Dose effect of influenza vaccine on protection against laboratory-confirmed influenza illness among children aged 6 months to 8 years of age in southern China, 2013/14-2015/16 seasons: a matched case-control study
    Fu, Chuanxi
    Greene, Carolyn M.
    He, Qing
    Liao, Ying
    Wan, Yanmin
    Shen, Jichuan
    Rong, Chao
    Zhou, Suizan
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (03) : 595 - 601
  • [22] Vaccine Effectiveness Against Laboratory-Confirmed Influenza in Children 6 to 59 Months of Age During the 2003-2004 and 2004-2005 Influenza Seasons
    Eisenberg, Katherine W.
    Szilagyi, Peter G.
    Fairbrother, Gerry
    Griffin, Marie R.
    Staat, Mary
    Shone, Laura P.
    Weinberg, Geoffrey A.
    Hall, Caroline B.
    Poehling, Katherine A.
    Edwards, Kathryn M.
    Lofthus, Geraldine
    Fisher, Susan G.
    Bridges, Carolyn B.
    Iwane, Marika K.
    PEDIATRICS, 2008, 122 (05) : 911 - 919
  • [23] Effectiveness of non-pharmaceutical measures in preventing pediatric influenza: a case-control study
    Torner, Nuria
    Soldevila, Nuria
    Jose Garcia, Juan
    Launes, Cristian
    Godoy, Pere
    Castilla, Jesus
    Dominguez, Angela
    BMC PUBLIC HEALTH, 2015, 15
  • [24] Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine in children and adolescents 6 months through 17 years of age in India
    Kalappanavar, Nijalingappa K.
    Ghosh, Apurba
    Sharma, Monika
    Ravichandran, Latha
    Choraria, Nirmal
    Saravanan, P.
    Pandey, Madhukar
    Pradeep, N.
    Shah, Prachee
    Nair, Sneha
    Shaikh, Ashfaque
    van de Witte, Serge
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (06)
  • [25] Differences between Frequentist and Bayesian inference in routine surveillance for influenza vaccine effectiveness: a test-negative case-control study
    Michael L. Jackson
    Jill Ferdinands
    Mary Patricia Nowalk
    Richard K. Zimmerman
    Burney Kieke
    Manjusha Gaglani
    Kempapura Murthy
    Joshua G. Petrie
    Emily T. Martin
    Jessie R. Chung
    Brendan Flannery
    Lisa A. Jackson
    BMC Public Health, 21
  • [26] Evaluation of Influenza Vaccine Effectiveness from 2021 to 2024: A Guangdong-Based Test-Negative Case-Control Study
    Zhu, Liyan
    Han, Ying
    Lu, Jiahai
    Tan, Jianhao
    Liao, Conghui
    Guo, Cheng
    He, Qing
    Qiu, Yajie
    Lu, Huahua
    Zhou, Yue
    Wei, Jianrui
    Hu, Dandan
    VACCINES, 2025, 13 (01)
  • [27] Differences between Frequentist and Bayesian inference in routine surveillance for influenza vaccine effectiveness: a test-negative case-control study
    Jackson, Michael L.
    Ferdinands, Jill
    Nowalk, Mary Patricia
    Zimmerman, Richard K.
    Kieke, Burney
    Gaglani, Manjusha
    Murthy, Kempapura
    Petrie, Joshua G.
    Martin, Emily T.
    Chung, Jessie R.
    Flannery, Brendan
    Jackson, Lisa A.
    BMC PUBLIC HEALTH, 2021, 21 (01)
  • [28] Seasonal influenza vaccine effectiveness in pre- and full-term children aged 6-23 months over multiple seasons
    Shen, Shixin
    Campitelli, Michael A.
    Calzavara, Andrew
    Guttmann, Astrid
    Kwong, Jeffrey C.
    VACCINE, 2013, 31 (29) : 2974 - 2978
  • [29] Relative Effectiveness of Adjuvanted Trivalent Inactivated Influenza Vaccine Versus Egg-derived Quadrivalent Inactivated Influenza Vaccines and High-dose Trivalent Influenza Vaccine in Preventing Influenza-related Medical Encounters in US Adults ≥ 65 Years During the 2017-2018 and 2018-2019 Influenza Seasons
    Boikos, Constantina
    Fischer, Lauren
    O'Brien, Dan
    Vasey, Joe
    Sylvester, Gregg C.
    Mansi, James A.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (05) : 816 - 823
  • [30] Influenza vaccine coverage among children under the age of 5 years in Poland during 2004-2008
    Nitsch-Osuch A.
    Kuchar E.
    Zycinska K.
    Topczewska-Cabanek A.
    Gyrczuk E.
    Wardyn K.
    European Journal of Medical Research, 15 (Suppl 2) : 102 - 104